SANDOZ CIPROFLOXACIN / DEXAMETHASONE

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: b508c1ef53154fee
Drug Approval Canada Name: SANDOZ CIPROFLOXACIN / DEXAMETHASONE
Product Name: SANDOZ CIPROFLOXACIN / DEXAMETHASONE
Status: Marketed
Status Date: 2021-01-26
Original Market Date: 2021-01-26
Din: 02506882
Drug Class: Human
Dosage Form: Suspension
Route Of Administration: Otic
Schedule: Prescription
Ahfs: 52:08.08
Atc Original: S02CA06 DEXAMETHASONE AND ANTIINFECTIVES
Atc Name: s 02 ca 06
Aig Number: 0250083001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

DEXAMETHASONE

0.1 % / W/V

CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)

0.3 % / W/V

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b508c1ef53154fee

Type

Standard